%D8%A7%D8%B9%D8%AA%D9%84%D8%A7%D9%84_%D8%A8%D9%8A%D8%B6%D8%A7%D8%A1_%D8%A7%D9%84%D8%AF%D9%85%D8%A7%D8%BA_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF_%D8%A7%D9%84%D8%A8%D8%A4%D8%B1_%D8%A7%D9%84%D9%85%D8%AA%D8%B1%D9%82%D9%8ALeucoencefalopatia_multifocal_progressivaCategory:Progressive_multifocal_leukoencephalopathyProgresivn%C3%AD_multifok%C3%A1ln%C3%AD_leukoencefalopatieProgressive_multifokale_LeukenzephalopathieProgressive_multifocal_leukoencephalopathyLeucoencefalopat%C3%ADa_multifocal_progresiva%D9%84%DA%A9%D9%88%D8%A7%D9%86%D8%B3%D9%81%D8%A7%D9%84%D9%88%D9%BE%D8%A7%D8%AA%DB%8C_%DA%86%D9%86%D8%AF%DA%A9%D8%A7%D9%86%D9%88%D9%86%DB%8C_%D9%BE%DB%8C%D8%B4%E2%80%8C%D8%B1%D9%88%D9%86%D8%AF%D9%87Progressiivinen_multifokaalinen_leukoenkefalopatiaLeucoenc%C3%A9phalopathie_multifocale_progressive%D7%97%D7%95%D7%9C%D7%99_%D7%9E%D7%95%D7%97_%D7%9E%D7%AA%D7%A7%D7%93%D7%9D_%D7%A8%D7%91-%D7%9E%D7%95%D7%A7%D7%93%D7%99Leukoensefalopati_multifokal_progresifLeucoencefalopatia_multifocale_progressiva%E9%80%B2%E8%A1%8C%E6%80%A7%E5%A4%9A%E5%B7%A3%E6%80%A7%E7%99%BD%E8%B3%AA%E8%84%B3%E7%97%87%EC%A7%84%ED%96%89%EC%84%B1_%EB%8B%A4%EC%B4%88%EC%A0%90_%EB%B0%B1%EC%A7%88%EB%87%8C%EB%B3%91%EC%A6%9DProgressieve_multifocale_leukencefalopathiePost%C4%99puj%C4%85ca_leukoencefalopatia_wieloogniskowaLeucoencefalopatia_multifocal_progressiva%D0%9F%D1%80%D0%BE%D0%B3%D1%80%D0%B5%D1%81%D1%81%D0%B8%D1%80%D1%83%D1%8E%D1%89%D0%B0%D1%8F_%D0%BC%D1%83%D0%BB%D1%8C%D1%82%D0%B8%D1%84%D0%BE%D0%BA%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F_%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D1%8D%D0%BD%D1%86%D0%B5%D1%84%D0%B0%D0%BB%D0%BE%D0%BF%D0%B0%D1%82%D0%B8%D1%8FQ704930%E8%BF%9B%E8%A1%8C%E6%80%A7%E5%A4%9A%E7%81%B6%E6%80%A7%E7%99%BD%E8%B4%A8%E8%84%91%E7%97%85
about
P2175
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainJC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathyEvaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathyUse of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literatureProgressive Multifocal LeukoencephalopathyProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesStratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert groupMultifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literatureNew insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathyTreatment-related progressive multifocal leukoencephalopathy: current understanding and future stepsJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Animal Models for Progressive Multifocal LeukoencephalopathyProgressive multifocal leukoencephalopathy: clinical and molecular aspectsThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyThe pathogenesis of progressive multifocal leukoencephalopathyProgressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literatureProgressive multifocal leukoencephalopathy: new conceptsProgressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapiesProgressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c BindingIs there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?Progressive multifocal leukoencephalopathy in a patient treated with natalizumabProgressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosisProgressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's diseaseProgressive multifocal leukoencephalopathy in patients on immunomodulatory therapiesMonoclonal antibodies and progressive multifocal leukoencephalopathyRemission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapyImproved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapyRisk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's DiseaseJC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of InfectionNatalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent RegistryFunctional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disordersProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy.Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.[New trends in progressive multifocal leukoencephalopathy]Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.[Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
P921
Q24619923-4DAE5379-973C-4B67-8C0B-5BDB12161E06Q24643911-7D7E0283-0F6D-4808-B9FB-F3B8F9A22300Q24683776-BBC6D6FE-884A-460C-AFB5-DC443DB61FBFQ26748590-5EB4DE9D-1A46-4756-8C5B-C61AFC9301BAQ26766172-C35D81B7-E7C3-465B-AD64-A9D11F20CC02Q26776236-8D17E627-8455-424D-A657-C5A22EC9B159Q26780412-703A836E-E640-4096-AB4E-C6997259FE32Q26781744-B649744D-2E81-476F-BF74-988528EFD002Q26822247-621ADC0D-0B88-4272-A15E-B2FA6FA757B3Q26823444-F33BAF97-DB1A-42E1-9212-46F3CD83B8CDQ26852060-6A37637F-3ED4-4399-9B68-0977A46CDEB3Q26853218-62CDF397-B8B6-4E75-A4EF-80B3A13A15A1Q26858968-8BAAF37E-4D5F-4E94-BDED-7DEFA8012D79Q26859307-031FBE2C-AA5A-40C4-8CD9-B105E963A64CQ26999906-4E5DE3D3-0704-47D5-B48C-579952692EE6Q27002045-DF66C221-A8E9-4C81-A431-0E20ACD93E3EQ27016148-5DD88858-BC0B-4EBC-97BF-4D4A7874C256Q27028025-840160CC-076C-4937-817F-B944DBD7B6C1Q27678593-036DF67C-0D67-495C-B998-655F59DB549EQ28084300-F7DA6B8B-659C-4A08-BD97-C9C9B74BAF13Q28255536-DB96E575-25D2-45B5-8D70-2423FDAAC36FQ28255548-646B3378-BC42-43D2-B777-F04D91C11B1AQ28255557-C149A800-B778-4CB5-A7EA-6F6A9B1AE787Q28256960-D5B92C61-079E-4AE6-9D71-C4CDEC01A713Q28270413-088581D2-E561-47AD-8D5A-7D232E40C297Q28371704-A1A48400-F7A7-4EB5-AB91-3439132DB894Q28478894-53DD48B7-420D-4E05-A044-253D293ECA91Q28538974-6580BD83-831B-43C4-AEA9-5361DB25E4DFQ28552120-398DF776-02D7-4FD0-BA89-A9CAFFD61E37Q28555138-80E22280-D2D1-46E9-B187-0619CEC4FF99Q28740884-A38E9A76-D433-4140-A7B1-EE66AAC47928Q30245002-3FEF60B8-4B21-4016-AD46-D9B021F31B4FQ30248790-13F850EE-65EE-4A86-9CEF-0F804AB290B8Q30249052-80452B23-282E-4525-897F-59ACA8FAEB66Q30327330-B6E43557-31EB-43D4-BA70-9E2F0CBCC78AQ30332766-266CFB5B-C29B-43C2-A9A9-36F4DD8D8571Q30351230-76BBBC96-9555-490F-B63A-92A95608D4DAQ30352753-77727C30-EA42-434F-8A74-D7DBEA452054Q30354301-4BD34CD0-A233-4FB2-A082-ADD2081F028DQ30355321-6538334E-FA66-4ADA-9AFB-562D4FEEA240
P921
description
Krankheit
@de
affection démyélinisante (affe ...... dépression cellulaire profonde
@fr
malattia virale rara e per lo ...... mielina in posizioni multiple
@it
viral disease affecting human brains
@en
viral disease affecting human brains
@en-gb
مرض يصيب الإنسان
@ar
name
Leucoencefalopatia multifocal progressiva
@pt-br
Postępująca leukoencefalopatia wieloogniskowa
@pl
Progressiivinen multifokaalinen leukoenkefalopatia
@fi
Progressive multifokale Leukenzephalopathie
@de
leucoencefalopatia multifocal progressiva
@ca
leucoencefalopatia multifocal progressiva
@pt
leucoencefalopatia multifocale progressiva
@it
leucoencefalopatía multifocal progresiva
@es
leucoencéphalopathie multifocale progressive
@fr
leukoensefalopati multifokal progresif
@id
type
label
Leucoencefalopatia multifocal progressiva
@pt-br
Postępująca leukoencefalopatia wieloogniskowa
@pl
Progressiivinen multifokaalinen leukoenkefalopatia
@fi
Progressive multifokale Leukenzephalopathie
@de
leucoencefalopatia multifocal progressiva
@ca
leucoencefalopatia multifocal progressiva
@pt
leucoencefalopatia multifocale progressiva
@it
leucoencefalopatía multifocal progresiva
@es
leucoencéphalopathie multifocale progressive
@fr
leukoensefalopati multifokal progresif
@id
altLabel
LEMP
@fr
Leucoencefalite multifocale progressiva
@it
Leucoencefalopatia multifocal progresiva
@es
Leucoencephalopathie multifocale progressive
@fr
Leucoencéphalopthie multifocale progressive
@fr
Leukoencephalopathy, progressive multifocal
@en
PML
@cs
PML
@en
PML
@en-gb
PML
@nn
prefLabel
Leucoencefalopatia multifocal progressiva
@pt-br
Postępująca leukoencefalopatia wieloogniskowa
@pl
Progressiivinen multifokaalinen leukoenkefalopatia
@fi
Progressive multifokale Leukenzephalopathie
@de
leucoencefalopatia multifocal progressiva
@ca
leucoencefalopatia multifocal progressiva
@pt
leucoencefalopatia multifocale progressiva
@it
leucoencefalopatía multifocal progresiva
@es
leucoencéphalopathie multifocale progressive
@fr
leukoensefalopati multifokal progresif
@id
P279
P2888
P31
P672
P486
P6366
P646
P672
P1325
P1417
topic/progressive-multifocal-leukoencephalopathy
P1550
P1692
P1748
P1995
P2176
P279
P2892
P373
Progressive multifocal leukoencephalopathy